Picture of Interpace Biosciences logo

IDXG Interpace Biosciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Interpace Biosciences Q3 Revenue USD 8.756 Million

Nov 12 (Reuters) - Interpace Biosciences Q3 net income USD 911 thousand.

Q3 operating expenses USD 4.294 million

Q3 gross profit USD 5.439 million

Q3 operating income USD 1.145 million

Recent news on Interpace Biosciences

See all news